Get started
AVECHO BIOTECHNOLOGY LIMITEDAVECHO BIOTECHNOLOGY LIMITEDAVECHO BIOTECHNOLOGY LIMITED

AVECHO BIOTECHNOLOGY LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

AVE chart


Full chart

Key stats


Market capitalization
‪12.68 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.001 AUD
Net income (FY)
‪−3.44 M‬ AUD
Revenue (FY)
‪473.55 K‬ AUD
Shares float
‪2.61 B‬
Beta (1Y)
0.71

About AVECHO BIOTECHNOLOGY LIMITED


Sector
Health Technology
CEO
Paul David Gavin
Headquarters
Clayton
Website
avecho.com.au
Founded
1992
ISIN
AU0000047441
FIGI
BBG000KD38P0
Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates under the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AVE news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AVE is 0.004 AUD — it has increased by 33.33% in the past 24 hours. Watch AVECHO BIOTECHNOLOGY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AVECHO BIOTECHNOLOGY LIMITED stocks are traded under the ticker AVE.
AVE stock has risen by 33.33% compared to the previous week, the month change is a 100.00% rise, over the last year AVECHO BIOTECHNOLOGY LIMITED has showed a 33.33% increase.
AVE reached its all-time high on Feb 19, 1996 with the price of 0.697 AUD, and its all-time low was 0.001 AUD and was reached on Oct 23, 2024. View more price dynamics on AVE chart.
See other stocks reaching their highest and lowest prices.
AVE stock is 33.33% volatile and has beta coefficient of 0.71. Track AVECHO BIOTECHNOLOGY LIMITED stock price on the chart and check out the list of the most volatile stocks — is AVECHO BIOTECHNOLOGY LIMITED there?
Yes, you can track AVECHO BIOTECHNOLOGY LIMITED financials in yearly and quarterly reports right on TradingView.
AVE net income for the last half-year is ‪−2.18 M‬ AUD, while the previous report showed ‪−1.31 M‬ AUD of net income which accounts for −66.17% change. Track more AVECHO BIOTECHNOLOGY LIMITED financial stats to get the full picture.
No, AVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AVECHO BIOTECHNOLOGY LIMITED EBITDA is ‪−4.81 M‬ AUD, and current EBITDA margin is −931.37%. See more stats in AVECHO BIOTECHNOLOGY LIMITED financial statements.
Like other stocks, AVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AVECHO BIOTECHNOLOGY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AVECHO BIOTECHNOLOGY LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AVECHO BIOTECHNOLOGY LIMITED stock shows the sell signal. See more of AVECHO BIOTECHNOLOGY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.